Shares of rapid test developer and manufacturer, Abingdon Health (LON: ABDX) closed over 13% lower on Monday after an article from the Daily Mail released on Friday evening said UK ministers “ignored legal advice to give a failing company a huge Covid test contract leaving taxpayers with an £87 million bill.”
That company is Abingdon Health, with the Daily Mail claiming that the tests didn’t work.
“Public Health England requires at least 98 per cent accuracy for antibody tests and its evaluation was that Abingdon’s offered less than 85 per cent,” the article said.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Abingdon’s share price closed at 90.5p, after a 13.76% fall on Monday.
The company did issue a brief response to the report, saying it “notes the article published in the Daily Mail on 6 February 2021 and refers investors to the RNS announcements made on 29 December 2020, 26 January 2021 and 27 January 2021 which accurately reflect the Company’s position and current performance.”
On 21 January, the government wrote to lawyers to say they had cancelled all outstanding orders placed with Abingdon Health for antibody lateral flow tests because they failed to gain approval from the MHRA for home use.
Judicial review proceedings have been brought against the government regarding the contract award to the company.
